# Mechanisms of Lorcaserin for Smoking Cessation

> **NCT04396834** · PHASE2 · TERMINATED · sponsor: **The Mind Research Network** · enrollment: 3 (actual)

## Conditions studied

- Tobacco Use Disorder
- Smoking Cessation

## Interventions

- **DRUG:** Lorcaserin Oral Tablet
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04396834
- **Lead sponsor:** The Mind Research Network
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-04
- **Primary completion:** 2020-02-26
- **Final completion:** 2020-02-26
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Medication removed from the U.S. market by the The Food and Drug Administration
- **Last updated:** 2023-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04396834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04396834, "Mechanisms of Lorcaserin for Smoking Cessation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04396834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*